George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVS Group Regulatory News (CVSG)

Share Price Information for CVS Group (CVSG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 976.00
Bid: 981.00
Ask: 983.00
Change: 1.00 (0.10%)
Spread: 2.00 (0.204%)
Open: 970.00
High: 991.00
Low: 970.00
Prev. Close: 975.00
CVSG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Exercise of Options, Directors' Dealing & TVR

19 Dec 2017 07:00

RNS Number : 7187Z
CVS Group plc
19 December 2017
 

18 December 2017

 

CVS Group plc

("CVS" or the "Company")

 

Exercise of Options, Directors' Dealing and Total Voting Rights

CVS, the UK's leading provider of integrated veterinary services, announces that on 18 December 2017, Simon Innes and Nick Perrin, Chief Executive and Finance Director of the Company respectively, together with certain other employees of the Company, exercised options at 0.2 pence per share over an aggregate of 243,205 ordinary shares of 0.2 pence each in the Company (the "New Shares"), under the CVS Group Long Term Incentive Plan 2014/2017. Simon Innes exercised options over 88,169 ordinary shares of 0.2p each in the Company ("Ordinary Shares") and Nick Perrin exercised options over 53,570 Ordinary Shares.

 

Application has been made for the New Shares, which rank pari passu in all respects with the Company's existing Ordinary Shares, to be admitted to trading on AIM which is expected to occur on or around 22 December 2017.

 

Following the issue of the New Shares, the Company's total issued share capital will consist of 64,159,080 Ordinary Shares with one voting right per share. The Company does not hold any Ordinary Shares in Treasury. Therefore, following the issue of the New Shares, the total number of voting rights in the Company will be 64,159,080. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

On 18 December 2017, the Company was notified that, on that date, Simon Innes sold 88,169 Ordinary Shares at a price of 1030 pence per Ordinary Share. Following the exercise and the sale, Simon Innes remains interested in 246,475 Ordinary Shares in the Company, representing 0.38 per cent of the total voting rights of the Company following the issue of the New Shares. The Company was also notified on 18 December 2017 that on that date, Nick Perrin sold 25,570 Ordinary Shares at a price of 1030 pence per Ordinary Share, retaining 28,000 of the Ordinary Shares arising from the exercise of his options. Following these events, Nick Perrin has increased his aggregate holding and is now interested in a total 60,000 Ordinary Shares in the Company, representing 0.09 per cent of the total voting rights of the Company following the issue of the New Shares.

 

The notifications below, made in accordance with the requirements of the EU Market Abuse Regulation, provide further detail.

 

Contacts:

 

CVS Group plc

Simon Innes, Chief Executive

Nick Perrin, Finance Director

 

Tel: 01379 644 288

 

N+1 Singer (Nominated Adviser & Broker)

Aubrey Powell

Liz Yong

James Hopton

 

Tel: 020 7496 3000

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Simon Innes

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Executive

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

CVS Group plc

b)

 

LEI

 

 

213800J41XDQ2NX48O05

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary shares of 0.2 pence each

 

 

GB00B2863827

 

b)

 

Nature of the transaction

 

 

Option Exercise

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

0.2 pence

88,169

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

 

- Price

 

 

 

88,169 Ordinary shares

 

 

1030 pence

e)

 

Date of the transaction

 

 

18 December 2017

f)

 

Place of the transaction

 

 

 Off Market

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Nick Perrin

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Finance Director

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

CVS Group plc

b)

 

LEI

 

 

213800J41XDQ2NX48O05

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary shares of 0.2 pence each

 

 

GB00B2863827

 

b)

 

Nature of the transaction

 

 

Option Exercise

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

0.2 pence

53,570

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

 

- Price

 

 

 

53,570

 

 

1030 pence

e)

 

Date of the transaction

 

 

18 December 2017

f)

 

Place of the transaction

 

 

Off Market

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Simon Innes

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Executive

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

CVS Group plc

b)

 

LEI

 

 

213800J41XDQ2NX48O05

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary shares of 0.2 pence each

 

 

GB00B2863827

 

b)

 

Nature of the transaction

 

 

Sale of ordinary shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

1030 pence

88,169

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

 

- Price

 

 

 

88,169

e)

 

Date of the transaction

 

 

18 December 2017

f)

 

Place of the transaction

 

 

London Stock Exchange (XLON)

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Nick Perrin

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Finance Director

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

CVS Group plc

b)

 

LEI

 

 

213800J41XDQ2NX48O05

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary shares of 0.2 pence each

 

 

GB00B2863827

 

b)

 

Nature of the transaction

 

 

Sale of ordinary shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

1030 pence

25,570

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

 

- Price

 

 

 

25,570

 

 

1030 pence

e)

 

Date of the transaction

 

 

18 December 2017

f)

 

Place of the transaction

 

 

London Stock Exchange (XLON)

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TVRGGGMAPUPMPGR
Date   Source Headline
5th Jan 20217:00 amRNSLong Term Incentive Plan Award
31st Dec 20207:00 amRNSExercise of Options
4th Dec 20209:34 amRNSGrant of Options under SAYE Scheme & PDMR Dealing
26th Nov 20203:49 pmRNSResult of AGM
26th Nov 20207:00 amRNSAGM Statement and Trading Update
23rd Nov 20207:00 amRNSHolding(s) in Company
9th Nov 20201:32 pmRNSLong Term Incentive Plan Awards & PDMR Dealing
6th Nov 20201:46 pmRNSHolding(s) in Company
4th Nov 20202:30 pmRNSPosting of Annual Report & Notice of AGM
30th Oct 20205:09 pmRNSExercise of Options
30th Sep 20207:00 amRNSExercise of Options
24th Sep 20207:00 amRNSFinal Results for the year ended 30 June 2020
4th Sep 202012:02 pmRNSPrice Monitoring Extension
28th Aug 20207:00 amRNSExercise of Options
18th Aug 20203:54 pmRNSHolding(s) in Company
31st Jul 20207:00 amRNSExercise of Options
24th Jul 20207:00 amRNSTrading Update
16th Jul 20207:00 amRNSBoard Appointment
30th Jun 202011:15 amRNSExercise of Options
26th Jun 20207:00 amRNSChange of Company Secretary
9th Jun 202012:29 pmRNSDirector/PDMR Shareholding
1st Jun 202011:50 amRNSExercise of Options
7th May 20209:10 amRNSHolding(s) in Company
30th Apr 202010:25 amRNSExercise of Options
14th Apr 20204:00 pmRNSHolding(s) in Company
9th Apr 202012:23 pmRNSHolding(s) in Company
2nd Apr 20202:29 pmRNSHolding(s) in Company
31st Mar 20201:42 pmRNSExercise of Options
30th Mar 202011:45 amRNSDirector/PDMR Shareholding
27th Mar 20202:52 pmRNSDirector/PDMR Shareholding
27th Mar 202012:02 pmRNSPrice Monitoring Extension
27th Mar 20209:54 amRNSFormatting Replacement: Interim Results
27th Mar 20207:00 amRNSInterim Results
20th Mar 20204:37 pmRNSPrice Monitoring Extension
16th Mar 20207:00 amRNSHolding(s) in Company
12th Mar 20209:34 amRNSHolding(s) in Company
9th Mar 20205:01 pmRNSHolding(s) in Company
9th Mar 20209:18 amRNSHolding(s) in Company
6th Mar 20205:27 pmRNSHolding(s) in Company
6th Mar 20202:47 pmRNSHolding(s) in Company
28th Feb 20207:00 amRNSExercise of Options
7th Feb 20207:00 amRNSTrading Update
31st Jan 20205:47 pmRNSOption exercise and block listing update
27th Jan 20204:12 pmRNSHolding(s) in Company
24th Jan 20204:22 pmRNSHolding(s) in Company
22nd Jan 20205:08 pmRNSHolding(s) in Company
20th Jan 20207:00 amRNSHolding(s) in Company
10th Jan 20203:46 pmRNSLong Term Incentive Plan Awards - replacement
10th Jan 20209:27 amRNSHolding(s) in Company
8th Jan 20203:57 pmRNSLong Term Incentive Plan Awards

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.